Alta Bates Comprehensive Cancer Center /ID# 1128-0135 — Berkeley, California

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 is a clinical research site located in Berkeley, California, United States 94704.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Berkeley

Browse all research sites in California · View every site in Berkeley

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alta Bates Comprehensive Cancer Center /ID# 1128-0135?

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alta Bates Comprehensive Cancer Center /ID# 1128-0135 conducted?

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma.

Is Alta Bates Comprehensive Cancer Center /ID# 1128-0135 accredited by Crixeo Clinical Trials?

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alta Bates Comprehensive Cancer Center /ID# 1128-0135?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.